当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析 - 现金流量表

中国医药

(600056)

  

流通市值:163.59亿  总市值:163.65亿
流通股本:14.95亿   总股本:14.96亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金16,726,433,633.227,251,831,214.3635,320,534,540.5525,292,280,947.71
  收到的税费返还67,253,052.1637,038,898.21127,069,084.37121,636,749.03
  收到其他与经营活动有关的现金551,064,558.97149,730,342.85796,381,084.761,169,260,231.02
  经营活动现金流入小计17,344,751,244.357,438,600,455.4236,243,984,709.6826,583,177,927.76
  购买商品、接受劳务支付的现金15,624,326,535.957,782,333,031.8831,283,451,498.623,458,767,242.83
  支付给职工以及为职工支付的现金806,685,508.31427,410,160.711,517,162,123.981,154,183,509.07
  支付的各项税费560,338,694.36256,686,197.4936,908,642.46852,772,560.64
  支付其他与经营活动有关的现金899,533,477.26453,747,307.851,501,031,895.021,437,881,227.61
  经营活动现金流出小计17,890,884,215.888,920,176,697.8435,238,554,160.0626,903,604,540.15
  经营活动产生的现金流量净额-546,132,971.53-1,481,576,242.421,005,430,549.62-320,426,612.39
二、投资活动产生的现金流量:
  取得投资收益收到的现金---1,367,693.93
  处置固定资产、无形资产和其他长期资产收回的现金净额17,687,076.198,187,430.1943,839,414.21143,223.19
  收到的其他与投资活动有关的现金9,862,663.63-3,6003,600
  投资活动现金流入小计27,549,739.828,187,430.1943,843,014.211,514,517.12
  购建固定资产、无形资产和其他长期资产支付的现金124,980,900.6861,362,248.21358,624,567.29241,151,821.22
  投资支付的现金--41,020,00040,000,000
  取得子公司及其他营业单位支付的现金4,134,7394,134,73911,855,061-
  投资活动现金流出小计129,115,639.6865,496,987.21411,499,628.29281,151,821.22
  投资活动产生的现金流量净额-101,565,899.86-57,309,557.02-367,656,614.08-279,637,304.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,000,000400,0009,000,0009,000,000
  其中:子公司吸收少数股东投资收到的现金4,000,000400,0009,000,0009,000,000
  取得借款收到的现金2,290,423,133.371,469,845,625.66,410,721,930.074,128,608,303.02
  收到其他与筹资活动有关的现金5,681,057.975,681,057.9772,281,229.7570,399,370.3
  筹资活动现金流入小计2,300,104,191.341,475,926,683.576,492,003,159.824,208,007,673.32
  偿还债务支付的现金2,105,060,985.381,264,424,3085,470,430,847.293,656,202,882.72
  分配股利、利润或偿付利息支付的现金196,667,100.0133,284,431.87589,214,420.16530,660,484.99
  其中:子公司支付给少数股东的股利、利润156,062,077.2-78,304,855.4865,979,591.38
  支付其他与筹资活动有关的现金723,346,681.24131,518,487.8690,591,802.18394,646,196.98
  筹资活动现金流出小计3,025,074,766.631,429,227,227.676,750,237,069.634,581,509,564.69
  筹资活动产生的现金流量净额-724,970,575.2946,699,455.9-258,233,909.81-373,501,891.37
四、汇率变动对现金及现金等价物的影响-1,024,669.09-842,648.331,779,865.311,887,281.63
五、现金及现金等价物净增加额-1,373,694,115.77-1,493,028,991.87381,319,891.04-971,678,526.23
  加:期初现金及现金等价物余额3,857,149,690.473,711,578,829.813,330,258,938.773,330,258,938.77
  期末现金及现金等价物余额2,483,455,574.72,218,549,837.943,711,578,829.812,358,580,412.54
补充资料:
  净利润375,327,120.46-686,623,882.02-
  资产减值准备-265,715.11-175,325,505.38-
  固定资产和投资性房地产折旧120,224,474.85-244,449,774.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧--244,449,774.72-
  无形资产摊销46,699,541.15-80,475,955.69-
  长期待摊费用摊销29,558,630.05-64,623,194.97-
  处置固定资产、无形资产和其他长期资产的损失-7,371,175.2--1,653,400.91-
  固定资产报废损失577,796.02--1,944,335.44-
  公允价值变动损失-5,891,042.55--127,466,901.01-
  财务费用-1,784,884.19-206,833,463.14-
  投资损失-28,354,956.85--18,690,363.11-
  递延所得税-14,057,919.65-2,641,680.61-
  其中:递延所得税资产减少-14,089,320.51--29,910,011.24-
    递延所得税负债增加31,400.86-32,551,691.85-
  存货的减少36,494,403.08-452,705,276.79-
  经营性应收项目的减少-1,933,735,919.06-1,882,963,521.95-
  经营性应付项目的增加614,650,987.78--2,964,554,965.04-
  不涉及现金收支的投资和筹资活动金额其他项目--89,281,494.46-
  现金的期末余额2,483,455,574.7-3,711,578,829.81-
  减:现金的期初余额3,853,292,207.58-3,330,258,938.77-
  减:现金等价物的期初余额3,857,482.89---
  现金及现金等价物的净增加额-1,373,694,115.77-381,319,891.04-
公告日期2025-08-282025-04-302025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑